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Abstract: A new scalemic 8,8a-dihydro caged xanthone (1) was isolated from the leaf extract of 24 
Garcinia propinqua. Five other known natural products, the three caged xanthones (2, 5 and 6) 25 
and the two neocaged xanthones, (3 and 4) were also isolated as scalemic mixtures. Their 26 
structures were characterized by spectroscopic methods. The enantiomeric ratios (er) of 27 
compounds 1-6 ranged from 1:0.7 to 1:0.9. These compounds were also resolved by 28 
semipreparative chiral HPLC. The absolute configurations of (+)-2 and (+)-3 were determined by 29 
single-crystal X-ray diffraction analysis using Cu Kα radiation while the absolute configurations 30 
of the other compounds were determined by comparisons of their ECD spectra. Compounds (−)-31 
4, (+)-4, (−)-5, (+)-5, and (−)-6 showed potent cytotoxicities against a colon cancer cell line 32 
HCT116 with IC50 values of 2.60, 7.02, 1.47, 3.37, and 4.14 µM, respectively, which were better 33 
than the standard control doxorubicin (IC50 9.74 µM).    34 
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1. Introduction 47 
Caged xanthones are commonly found in Garcinia (Clusiaceae) [1-23] and many of them 48 
show interesting biological activities, especially cytotoxicity against several cancer cell lines [1-49 
3,5,6,12,13,19]. One of the best-known caged xanthones is (‒)-gambogic acid, a major 50 
component from the exuded resin of G. hanburyi, first isolated in 1949 by Land and Katz [14] 51 
which has been found to be cytotoxic for various cancer cell lines [21]. So far, over 100 caged 52 
xanthones have been isolated and identified from Garcinia [1-23]. Some of these have been 53 
isolated as scalemic mixtures or reported to have specific rotations of relatively small 54 
magnitudes [3,5,9,10,12,20].  In a previous study, we reported the isolation seven new scalemic 55 
caged xanthones from the stem bark extract of G. propinqua. Six of them were successfully 56 
resolved by chiral HPLC and their absolute configurations were determined [22]. In continuation 57 
of our study on the different parts of this plant (Fig. 1), we report herein the resolution and 58 
absolute configuration assignment of six scalemic caged xanthones, 1-6 (Fig. 2), isolated from 59 
the leaf extract of G. propinqua, collected from Doi Tung, Chiang Rai Province, Thailand. The 60 
cytotoxicities of the resolved caged xanthones against a colon cancer cell line are also reported.  61 
2. Experimental  62 
2.1. General  63 
Melting points were measured on a Buchi melting point B-540 visual thermometer. The 64 
optical rotation values were measured with a Bellingham & Stanley APD440 polarimeter. The 65 
UV spectra were recorded with a Perkin-Elmer UV-vis or Varian Cary 5000 UV-Vis-NIR 66 
spectrophotometer. Infrared (IR) spectra were recorded on a PerkinElmer FTS FT-IR or 67 
PerkinElmer Frontier Optica FT-IR spectrophotometers. Electronic circular dichroism spectra 68 
were recorded on a JASCO J-815 spectrometer. The 1D and 2D NMR spectra data were obtained 69 
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on a 600 MHz Bruker AV-600 spectrometers in CDCl3 with TMS as the internal standard. 70 
Chemical shifts are reported in parts per million (δ), and coupling constants (J) are expressed in 71 
hertz. Low- and high-resolution MS were recorded using ESI ionization and a TOF mass 72 
analyzer. Chiral HPLC was performed on a CHIRALPAK IA 15 column of 10 × 250 mm or 73 
CHIRALCEL OD-H column of 4.6 × 250 mm and attached to Waters 2487 Dual λ Absorbance 74 
detector. Quick column chromatography (QCC) and column chromatography (CC) were carried 75 
out on silica gel 60 H (5-40 µm, SiliCycle Inc.) and silica gel 100 (63-200 µm, SiliCycle Inc.), 76 
respectively. Sephadex LH-20 was also used for CC. Precoated plates of silica gel 60 F254 were 77 
used for analytical purposes. 78 
2.2 Plant material  79 
The leaves of G. propinqua were collected from Doi Tung, Chiang Rai Province, 80 
Thailand in September 2011. The plant was identified by Mr. Matin Van de Bult (Doi Tung 81 
Development Project, Chiang Rai, Thailand), and the specimen (MFU-NPR0090) was deposited 82 
at the Natural Products Research Laboratory, School of Science, Mae Fah Luang University. 83 
2.3. Extraction and isolation  84 
Chopped and dried leaves of G. propinqua (2.5 kg) were extracted with MeOH (10 L) for 85 
three days at room temperature. Removal of the solvent under reduced pressure provided the 86 
crude extract (196 g), which was partitioned between water and CH2Cl2. The CH2Cl2 extract (96 87 
g) was subjected to QCC over silica gel (100% hexanes to 100% EtOAc) to give 24 fractions 88 
(P1-P24). Fraction P3 (300 mg) was further fractionated by QCC (100% hexanes to 100% 89 
EtOAc) to afford seven subfractions (P3A-P3G). Subfraction P3D (100 mg) was further 90 
fractionated by CC (3:7 CH2Cl2/hexanes) to provide five subfractions (P3D1-P3D5). Compound 91 
7 (2.3 mg) were obtained from subfraction P3D2 (10 mg) by PLC (1:19 EtOAc/hexanes). 92 
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Subfraction P3C (10 mg) was further separated by PLC (1:19 EtOAc/hexanes) to give 93 
compounds 16 (2.3 mg) and 8 (2.9 mg). Compounds 5 (13.9 mg), 3 (8.7 mg), 6 (14.4 mg), and 94 
11 (4.8 mg) were obtained from fraction P14 (62 mg), P15 (55 mg), P11 (50 mg), and P7 (30 95 
mg), respectively, by washing with hexanes. Fraction P8 (500 mg) was separated CC (1:9 96 
acetone/hexanes) to give three subfractions (P8A-P8C). Compound 12 (6.0 mg) was obtained 97 
from subfraction P8C (42 mg), whereas compound 9 (10.8 mg) was isolated from subfraction 98 
P8B (30 mg) by Sephadex LH-20 (100% MeOH). Compound 4 (9.5 mg) was obtained from 99 
subfraction P8A (50 mg) by CC (3:2 CH2Cl2/hexanes). Fraction P21 (500 mg) was further 100 
separated by Sephadex LH-20 (100% MeOH) to give compound 13 (13.0 mg). Fraction P9 (200 101 
mg) was fractionated by Sephadex LH-20 (100% MeOH) to give three subfractions (P9A-P9C). 102 
Compound 2 (28.7 mg) was isolated from subfraction P9B (40 mg) by CC (1:9 acetone/hexanes). 103 
Fraction P18 (300 mg) was washed with hexanes to give compound 14 (4.5 mg) and the mother 104 
liquor of P18 was further separated by Sephadex LH-20 (100% MeOH) to give three 105 
subfractions (P18A-P18C). Compound 1 (16.2 mg) was isolated from subfraction P18A (50 mg). 106 
Finally, fraction P16 (200 mg) was separated by CC (1:9 acetone/hexanes) to give compounds 10 107 
(4.3 mg), 17 (5.3 mg), and 15 (3.4 mg). 108 
2.4. Compound 1  109 
White solid; m.p. 221‒223 °C; UV (MeOH) λmax (log ε) 219 (3.81), 297 (3.65), and 337 110 
(2.92) nm; IR (neat) νmax 3436, 1740, 1638 cm
-1; 1H NMR  and 13C NMR data, see Tables 1 and 111 
2; ESITOFHRMS m/z 497.2547 [M+H]+ (calcd for C29H37O7, 497.2539). 112 
2.5 Resolution of compound 1 and ECD spectroscopic data of (‒)-1 and (+)-1  113 
Resolution of the two enantiomers of 1 (15.0 mg) was performed by semi-preparative 114 
HPLC on a chiral column (CHIRALPACK IA 15 µL, 10 × 250 mm, flow rate 1 mL/min, n-115 
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hexane/iPrOH, 99:1 v/v). Compound (‒)-1 (tR 90 min) [(7.3 mg), []
 ‒66.6 (c 0.1, CHCl3)]; 116 
ECD (MeOH) λmax (∆ε) 224 (+0.85 × 10
2) and 306 (−0.88×102) nm] and (+)-1 (tR 95 min) [(4.7 117 
mg), []

 +56.5 (c 0.1, CHCl3)]; ECD (MeOH) λmax (∆ε) 224 (-0.92 × 10
2) and 306 (+0.99 × 118 
102) nm] were obtained.  119 
2.6. Compound 2  120 
Yellow solid; m.p. 180‒184 °C; UV (MeOH) λmax (log ε) 216 (3.16), 310 (2.64), 328 121 
(2.83), and 355 (2.96) nm; IR (neat) νmax 3462, 1739, 1635 cm
-1; 1H and 13C NMR data, see 122 
Tables 1 and 2; ESITOFHRMS m/z 487.2094 [M+Na]+ (calcd for C28H32NaO6, 487.2097). 123 
2.7 Resolution of compound 2 and ECD spectroscopic data of (‒)-2 and (+)-2 124 
Resolution of two enantiomers of 2 (10.0 mg) was performed by semi-preparative HPLC 125 
on a chiral column (CHIRALCEL OD-H, 4.6 × 250 mm, flow rate 1 mL/min, n-hexane/iPrOH, 126 
98:2 v/v). Compound (‒)-2 (tR 45 min) [(3.5 mg), []
 −24.2 (c 0.07, CHCl3); ECD (MeOH) 127 
λmax (∆ε) 209 (+0.32 × 10
2), 219 (−0.04 × 102), 236 (+0.09 × 102), 262 (+0.31 × 102), 280 (+0.42 128 
× 102), 306 (+0.39 × 102), and 350 (−1.13 × 102) nm] and (+)-2 (tR 48 min) [(2.9 mg), []
 129 
+38.2 (c 0.06, CHCl3); ECD (MeOH) λmax (∆ε) 208 (−0.64 × 10
2), 227 (+0.03 × 102), 239 (−0.12 130 
× 102), 263 (−0.30 × 102), 280 (−0.40 × 102), 306 (−0.35 × 102), and 350 (+0.88 × 102) nm].  131 
2.8. Compound 3 132 
Yellow solid; m.p. 178‒182 °C; UV (MeOH) λmax (log ε) 213 (3.23), 252 (2.61), and 342 133 
(3.02) nm; IR (neat) νmax 3406, 1749, 1634 cm
-1; 1H and 13C NMR data, see Tables 1 and 2; 134 
ESITOFHRMS m/z 501.2254 [M+Na]+ (calcd for C29H34NaO6, 501.2253). 135 
2.9. Resolution of compound 3 and ECD spectroscopic data of (‒)-3 and (+)-3  136 
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Resolution of the two enantiomers of 3 (8.4 mg) was performed by the method described 137 
for 1, to give compounds (‒)-3 (tR 70 min) [(4.0 mg), []
 −27.7 (c 0.08, MeOH); ECD (MeOH) 138 
λmax (∆ε) 232 (+0.82 × 10
2), 260 (+0.52 × 102), 310 (−0.53 × 102), 348 (+0.13 × 102), and 360 139 
(+0.14 × 102) nm]  and (+)-3 (tR 75 min) [(3.6 mg), []
 +34.4 (c 0.07, MeOH); ECD (MeOH) 140 
λmax (∆ε) 231 (−1.11 × 10
2), 258 (−0.67 × 102), 304 (+0.65 × 102), 316 (+0.72 × 102), 345 (−0.08 141 
× 102) and 358 (−0.25 × 102) nm].  142 
2.10. Compound 4  143 
Yellow solid; m.p. 187–192 °C; UV (MeOH) λmax (log ε) 211 (3.48), 257 (2.94), 306 144 
(2.89), and 343 (3.23) nm; IR (neat) νmax 3387, 1750, 1637 cm
-1; 1H and 13C NMR data, see 145 
Tables 1 and 2; ESITOFHRMS m/z 463.2125 [M–H]− (calcd for C28H31O6, 463.2121). 146 
2.11. Resolution of compound 4 and ECD spectroscopic data of (‒)-4 and (+)-4  147 
Resolution of the two enantiomers of 4 (13.0 mg) was performed by the method 148 
described for 2, to give compounds (‒)-4 (tR 18 min) [(5.2 mg), []
 −28.3 (c 0.1, MeOH); ECD 149 
(MeOH) λmax (∆ε) 238 (+0.61 × 10
2), 262 (+0.49 × 102), 301 (−0.34×102), and 341 (−0.22 × 102) 150 
nm] and (+)-4 (tR 21 min) [(4.8 mg), []
 +37.4 (c 0.1, MeOH); ECD (MeOH) λmax (∆ε) 237 151 
(−0.72 × 102), 262 (−0.57 × 102), 301 (+0.39 × 102), and 341 (+0.24 × 102) nm].  152 
2.12. Compound 5 153 
Yellow solid; m.p. 140‒144 °C; UV (MeOH) λmax (log ε) 218 (3.20), 297 (2.75), 326 154 
(2.68), and 350 (2.75) nm; IR (neat) νmax 3456, 1737, 1636 cm
-1; 1H and 13C NMR data, see 155 
Tables 1 and 2; ESITOFHRMS m/z 501.2249 [M+Na]+ (calcd for C29H34NaO6, 501.2253). 156 
2.13. Resolution of compound 5 and ECD spectroscopic data of (+)-5 and (‒)-5  157 
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Resolution of the two enantiomers of 5 (20.0 mg) was performed by the method 158 
described for 2, to give compounds (‒)-5 (tR 5 min) [(4.6 mg) , []
 ‒74 (c 0.1, MeOH); ECD 159 
(MeOH) λmax (∆ε) 210 (+0.44 × 10
2), 234 (−0.13 × 102), 260 (+0.12 × 102), 285 (+0.20 × 102), 160 
313 (+0.29 × 102), and 350 (−0.60 × 102) nm] and (+)-5 (tR 7 min) [(4.9 mg), []
 +58 (c 0.1, 161 
MeOH); ECD (MeOH) λmax (∆ε) 235 (+0.04 × 10
2), 264 (−0.09 × 102), 283 (−0.10 × 102), 315 162 
(−0.12 × 102), and 350 (+0.34 × 102) nm]. 163 
2.14. Resolution of compound 6 and ECD spectroscopic data of (+)-6 and (‒)-6 164 
Resolution of the two enantiomers of 6 (20.0 mg) was performed by the method 165 
described for 2, to give compounds (‒)-6 (tR 15 min) [(3.0 mg) , []
 ‒83 (c 0.06, MeOH); ECD 166 
(MeOH) λmax (∆ε) 211 (+1.10 × 10
2), 229 (−0.42 × 102), 263 (+0.47 × 102), 282 (+0.67 × 102), 167 
310 (+0.69 × 102), and 352 (−1.65 × 102) nm] and (+)-6 (tR 17 min) [(3.5 mg), []
 +96 (c 0.07, 168 
MeOH); ECD (MeOH) λmax (∆ε) 209 (−0.87 × 10
2), 229 (+0.29 × 102), 265 (−0.38 × 102), 282 169 
(−0.51 × 102), 310 (−0.53 × 102), and 352 (+1.30 × 102) nm]. 170 
2.15. X-ray crystallographic analysis of compounds (+)-2, (+)-3 and scalemic mixture 4 171 
Single-crystal X-ray diffraction analysis was collected on a Bruker APEX DUO 172 
diffractometer with cross-coupled multilayer optics Cu-Kα radiation. Data were corrected for 173 
absorption effects using the multi-scan technique (SADABS). The structure was solved by direct 174 
methods.  175 
Single-crystal X-ray data for (+)-2: Yellow tablet crystal of C28H32O6, M = 464.53, 176 
crystal system orthorhombic with a = 10.0612(7) Å, b = 11.6588(8) Å, c = 19.8385(13) Å, α = 177 
90°, β = 90°, γ = 90°, v = 2327.1(3) Å, and chiral group P212121, z = 4. The X-ray diffraction 178 
analysis using Cu-Ka radiation values were 7.50 cm-1, 22624 reflections measured, 4027 179 
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independent reflections (Rint = 0.035). Final R indices: R1 = 0.029 and wR2 = 0.074. The standard 180 
deviation of an observation of unit weight was 1.03.  The absolute configurations of (+)-2 was 181 
assigned as 5S, 7R, 10aR, 22R (Fig. 4) with a Flack x-parameter of 0.06(5). 182 
Single crystal X-ray data for (+)-3: Yellow tablet crystal of C29H34O6, M = 478.56, crystal 183 
system monoclinic with a = 11.7599(7) Å, b = 36.717(2) Å, c = 17.2160(9) Å, α = 90°, β = 184 
90.767(3)°, γ = 90°, v = 7433.0(7) Å, and chiral group P21, z = 12. The x-ray diffraction analysis 185 
using Cu-Ka radiation values were 7.19 cm-1, 97789 reflections measured, 26173 independent 186 
reflections (Rint = 0.070). Final R indices: R1 = 0.056 and wR2 = 0.142. The standard deviation of 187 
an observation of unit weight was 1.04. The absolute configurations of compound (+)-3 was 188 
assigned as 6S, 7R, 10aS, 22S (Fig. 4) with a Flack x-parameter of -0.12(8). 189 
Single-crystal X-ray data for scalemic mixture 4: Yellow irregular crystal of C28H32O6, M 190 
= 464.53, crystal system orthorhombic with a = 19.5660(8) Å, b = 8.0604(3) Å, c = 14.3543(6) 191 
Å, α = 90°, β = 90°, γ = 90°, v = 2263.81(6) Å, and chiral group Pca21, z = 4. The x-ray 192 
diffraction analysis using Cu-Ka radiation values were 7.71 cm-1, 12938 reflections measured, 193 
3570 independent reflections (Rint = 0.039). Final R indices: R1 [I > 2.00σ (I)] = 0.032 and wR2 = 194 
0.083, respectively. The standard deviation of an observation of unit weight was 1.06.  195 
The X-ray Crystallographic data for compounds (+)-2, (+)-3 and scalemic mixture 4 have 196 
been deposited with the Cambridge Crystallographic Data Centre with deposition number CCDC 197 
1539175 for (+)-2, CCDC 1539176 for (+)-3 and CCDC 1539178 for scalemic mixture 4. These 198 
data can be obtained free of charge from the Cambridge Crystallographic Data Centre via 199 
www.ccdc.cam.ac.uk/data_request/cif. 200 
2.16. Cytotoxic Assay 201 
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Determination of the cytotoxicities of compounds on colon cancer cell (HCT116, 202 
American Type Culture Collection (ATCC), Manassas, VA, USA) was performed by the 203 
previous method [22]. Briefly, HCT116 cells (1 × 104 cells/well) were cultured in 96 well plate 204 
at 37 ºC for 24 h which were treated with compounds (10 µM in DMSO) in DMEM medium for 205 
24 h. The medium was removed and fresh DMEM containing 0.5 mg/mL of MTT solution was 206 
added for 2 h. After removal of medium, the violet formazan crystals were dissolved in DMSO 207 
(100 µL) and the absorbance was measured at 570 nm using a microplate reader. Doxorubicin 208 
(IC50 9.74 µM) was used as a positive control.  209 
%cell viability =  
	
	
		
	
	
	

	
 × 100 210 
                    %cytotoxicity = 100 ‒ %cell viability 211 
 212 
3. Results and discussion 213 
 Compound 1 was obtained as a white solid with m.p. 221‒223 °C. Its molecular formula 214 
was determined as C29H36O7, from its protonated molecular ion at m/z 497.2547 [M+H]
+ (calcd 215 
for 497.2539) in the ESITOFHRMS. The UV spectrum showed absorption bands at λmax 219, 216 
297, and 337 nm. The IR spectrum contained absorption bands at 3436, 1638, and 1740 cm-1 217 
indicating the presence of a hydroxy group and conjugated carbonyl and unconjugated carbonyl 218 
groups. The 1H and 13C NMR spectra of compound 1 (Table 1), which were similar to those of 219 
doitunggarcinone F22 isolated from the stem bark of G. propinqua, displayed resonances for: a 220 
H-bonded hydroxy proton [δH 12.09 (1H, s, OH-1)], an isolated aromatic proton [δH 6.08 (1H, s, 221 
H-2)/δC 99.5], a methoxy group [δH 3.29/δC 55.7], three methine protons [δH 4.35 (1H, dd, J = 222 
4.4, 1.4 Hz, H-8)/δC 74.6, δH 2.88 (1H, dd, J = 4.5, 5.9 Hz, H-7)/δC 44.7, δH 3.30 (1H, d, J = 1.4 223 
Hz, H-8a)/δC 47.2], a 1,1-dimethylallyl moiety [δH 6.24 (1H, dd, J = 10.5, 17.9 Hz, H-12)/δC 224 
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149.2, δH 5.35 (1H, d, J = 17.9 Hz, H-13a)/δC 113.4, δH 5.30 (1H, d, J = 10.5 Hz, H-13b)/δC 225 
113.4, δH 1.66 (3H, s, H3-15)/δC 27.3, and δH 1.62 (3H, s, H3-14)/δC 30.3], a (‒OC(Me)2‒226 
CHCH2‒C‒) unit [δH 2.54 (1H, d, J = 8.7 Hz, H-22)/δC 43.9, δH 1.97 (1H, dd, J = 6.3, 14.7 Hz, 227 
H-21a)/δC 20.2, δH 1.39 (3H, s, H3-25)/δC 30.5, δH 1.38 (1H, dd, J = 8.7, 14.7 Hz, H-21b)/δC 228 
20.2, and δH 1.12 (3H, s, H3-24)/δC 27.4] and a prenyl group [δH 5.29 (1H, m, H-17)/δC 117.8, δH 229 
2.86 (1H, dd, J = 14.6, 5.9 Hz, H-16a), δH 2.69 (1H, dd, J = 14.6, 9.1 Hz, H-16b)/δC 28.1, δH 230 
1.66 (3H, s, H3-20)/δC 26.0 and δH 1.62 (3H, s, H3-19)/δC 18.0]. The only difference between the 231 
structures of compound 1 and doitunggarcinone F is that compound 1 had a C-3 hydroxy group 232 
(δH 6.96, s) while the latter compound had a C-3 methoxy group. In the HMBC spectrum, the C-233 
3 hydroxy group showed cross-peaks with C-3 (δC 165.5) and C-4 (δC 111.4) (Fig. 3). Compound 234 
1 was therefore identified as doitunggarcinone L.   235 
Similar to doitunggarcinones F-K, previously isolated from the stem bark of this plant 236 
[22], doitunggarcinone L (1) could be resolved by semipreparative chiral HPLC to give 237 
compounds (−)-1 (tR 90 min), []
 ‒66.6 (c 0.1, CHCl3) and (+)-1 (tR 95 min), []
 +56.5 (c 238 
0.1, CHCl3) in a ratio of ca 1:0.9 (Fig. S31, Supplementary material). The absolute 239 
configurations of (−)-1 and (+)-1 were identified by comparisons of their ECD spectra with those 240 
of (−)-doitunggarcinone F and (+)-doitunggarcinone F [22]. The ECD spectrum of (−)-1 showed 241 
a positive Cotton effect around 224 and a negative effect around 306 nm, while (+)-1 exhibited 242 
opposite signs of Cotton effects at those same wavelengths (Fig. 5), which were similar to those 243 
of (−)-doitunggarcinone F22 and (+)-doitunggarcinone F [22], respectively. Thus, the absolute 244 
configuration of (−)-1 was assigned as 5R, 7S, 8S, 8aR, 10aR, 22S and the configuration of (+)-1 245 
was assigned as 5S, 7R, 8R, 8aS, 10aR, 22R. Compounds (‒)-1 and (+)-1 were assigned trivial 246 
names as (‒)-doitunggarcinone L and (+)-doitunggarcinone L, respectively.  247 
12 
 
Compounds 2-5 were identified as isobractatin (2) [5], 3-O-methylneobractatin (3) [10], 248 
neobractatin (4) [10] and 3-O-methylbractatin (5) [10], by spectroscopic methods including 249 
NMR, ESITOFHRMS, UV, and IR as well as comparisons with literature data. The structure of 250 
compound 4 was also confirmed by single crystal X-ray diffraction analysis (Fig. 4). Compounds 251 
2-5 were previously isolated from G. bracteata, with all having specific rotations of relatively 252 
small magnitudes. Isobractatin (2), []  ‒3 (c 0.58, CHCl3), was first isolated from the leaf 253 
extract of G. bracteata in 2000 by Thoison et al. [5] and was shown to be a scalemic mixture by 254 
analytical chiral HPLC analysis [5]. Compounds 3-5 were first isolated from the twig extract of 255 
G. bracteata by Na et al. in 2010 [10]. They had specific rotations of []
 +5.4 (c 0.17, MeOH) 256 
for 3 [10],  []
 +9.4 (c 0.24, MeOH) for 4 [10], and []
 ‒1.3 (c 0. 44, MeOH) for 5 [10]. In 257 
this study, compounds 2-5 were resolved by semiprepatative chiral HPLC. All of them were 258 
scalemic mixtures with enantiomeric ratios (er) ranging from 1:0.7 to 1:0.9: Compound 2 (er = 259 
1:0.8; (‒)-2, tR 45 min, []
 ‒24.2 (c 0.07, CHCl3)/(+)-2, tR 48 min, []
 +38.2 (c 0.06, 260 
CHCl3)]), compound 3 ( er = 1:0.9; (‒)-3, tR 70 min, []
 ‒27.7 (c 0.08, MeOH)/(+)-3, tR 75 261 
min, []
 +34.4 (c 0.07, MeOH), compound 4 (er = 1:0.7; (‒)-4, tR 18 min, []
 ‒28.3 (c 0.1, 262 
MeOH)/(+)-4, tR 21 min, []
 +37.4 (c 0.1, MeOH) and compound 5 (er = 1:0.8; (‒)-5, tR 5 263 
min, []

 ‒74 (c 0.1, MeOH)/(+)-5, tR 7 min, []
 +58 (c 0.1, MeOH) (Fig. S31, 264 
Supplementary material). Each pair of enantiomers displayed identical 1H and 13C NMR spectra 265 
(Tables 1 and 2). Compounds (+)-2 and (+)-3 produced single crystals from CH2Cl2/MeOH (1:3 266 
v/v) which were subjected to X-ray diffraction analysis using Cu Kα radiation to determine their 267 
absolute configurations.  268 
From the X-ray data analysis, the absolute configuration of (+)-2 (Fig. 4) was established 269 
as 5S, 7R, 10aR, 22R with a Flack x-parameter of 0.06(5). The ECD spectrum of (+)-2 (Fig. 5) 270 
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displayed a strong positive Cotton effect around 350 nm and negative Cotton effects around 208 271 
and 280 nm. Thus, the absolute configuration of (‒)-2, was assigned as 5R, 7S, 10aS, 22S 272 
because of its opposite signs of ECD Cotton effects (Fig. 5) as well as specific rotation, []
 ‒273 
24.2 (c 0.07, CHCl3), to that of (+)-2, []
 +38.2 (c 0.06, CHCl3). The trivial names (+)-274 
isobractatin and (‒)-isobractatin were given for (+)-2 and (‒)-2, respectively.     275 
The absolute configuration 6S, 7R, 10aS, 22S of (+)-3,	[]
 +34.4 (c 0.07, MeOH), was 276 
established on the basis of single-crystal X-ray diffraction analysis (Fig. 4) with a Flack x-277 
parameter of ‒0.12(8). Compound (−)-3, []
 ‒27.7 (c 0.08, MeOH), presented reverse 278 
absorption curves in the ECD spectrum (Fig. 5) indicating the absolute configuration of 6R, 7S, 279 
10aR, 22R.  Thus, (+)-3-O-methylneobractatin and (‒)-3-O-methylneobractatin were assigned for 280 
compounds (+)-3 and (‒)-3, respectively.  281 
The absolute configuration 6R, 7S, 10aR, 22R of (‒)-4 and 6S, 7R, 10aS, 22S of (+)-4 282 
were established by the comparisons of their ECD spectra (Fig. 5) and specific rotations ([]
 ‒283 
28.3 (c 0.1, MeOH) for (‒)-4 and ([]
 +37.4 (c 0.1, MeOH) for (+)-4) to those of (‒)-3 and (+)-284 
3. Therefore, compound (+)-4 and (−)-4 were assigned names as (+)-neobractatin and (‒)-285 
neobractatin, respectively.  286 
Compound (‒)-5 displayed ECD Cotton effects (Fig. 5) and specific rotation, []
 ‒74 287 
(c 0.1, MeOH), similar to those of (‒)-cochinchinone C.24 Thus, its absolute configuration was 288 
assigned as 5R, 7S, 10aS, 22S. The absolute configuration 5S, 7R, 10aR, 22R assigned to (+)-5 289 
was identified from the opposite signs of its ECD Cotton effects (Fig. 5) and specific rotation, 290 
[]
 +58 (c 0.1, MeOH), with those of (‒)-5. The names of (+)-5 and (‒)-5 were assigned as (+)-291 
3-O-methylbractatin and (‒)-3-O-methylbractatin, respectively.     292 
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Bractatin (6) was previously resolved into its two enantiomers but their absolute 293 
configurations were not determined [5]. In this study, bractatin was resolved by semipreparative 294 
chiral HPLC which showed two peaks, tR 15 min for (‒)-6 ([]
 ‒83 (c 0.06, MeOH)) and 17 295 
min for (+)-6 ([]
 +96 (c 0.07, MeOH)), (Fig. S31, Supplementary material) with an 296 
approximately enantiomeric ratio ca 1:0.7 ((‒)-6/(+)-6). The ECD spectra of (+)-6 and (‒)-6 (Fig. 297 
5) were similar to those of (+)-5 and (‒)-5, respectively, indicating their absolute configurations 298 
were 5S, 7R, 10aR, 22R for (+)-6 and 5R, 7S, 10aS, 22S for (‒)-6.  299 
Possible biosynthetic pathways for the generation of the caged xanthones 1-6 are shown 300 
in Scheme 1. The intermediate 13.1 could be obtained from xanthone 13 via double O-301 
prenylation at C-5 and C-6 [22]. Claisen rearrangement of 13.1 could generate intermediate 13.2 302 
(carbonyl group at C-6) or intermediate 13.3 (carbonyl group at C-5). These intermediates could 303 
then produce caged molecules having different bridge-head structures. Using the dextroisomer 304 
(+)-6 for example, containing a caged bridge-head at C-5/C-7/C-10a, this molecule could be 305 
obtained from intermediate 13.2 via an intramolecular Diels-Alder reaction. The cyclization of 306 
the 3-OH onto the C-12 olefinic moiety of (+)-6 would give compound (+)-2, whereas O-307 
methylation at C-3 would produce compound (+)-5. In addition, the oxidation of (+)-6 at C-8/C-308 
8a and then O-methylation at C-8 would give compound (+)-1. While caged compound (+)-3 309 
with a different bridge-head, at C-6/C-7/C-10a, (called a neocaged xanthone) could obtain from 310 
intermediate 13.3 via an intramolecular Diels-Alder reaction. O-methylation at C-3 of compound 311 
(+)-3 would then give compound (+)-4. 312 
The remaining compounds were identified as doitunggarcinone A (7) [25, 26], 313 
doitunggarcinone B (8) [25, 26], morusignin J (9) [27], 1,3,5-trihydroxy-6´,6-dimethylpyrano 314 
(2´-2´,6,7)-4-(1,1-dimethylprop-2-enyl)-xanthone (10) [28], gartanin (11) [29], allanxanthone A 315 
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(12) [30], gerontoxanthone I (13) [31], 1,3,5,6-tetrahydroxy-4(1,1-dimethylprop-2-enyl)-7-(3-316 
methylbut-2-enyl)-xanthone (14) [28], 1,3,7-trihydroxy-2,4-diisoprenylxanthone (15) [32], 317 
blancoxanthone (16) [33], 10-O-methylmacluraxanthone (17) [34], (Fig. 2) by spectroscopic 318 
methods as well as comparisons with the literature.  319 
 Caged xanthones 1-6 were evaluated for their cytotoxicities against the colon cancer cell 320 
line (HCT116). Compounds (−)-4, (+)-4, (−)-5, (+)-5, and (−)-6, showed potent inhibitory 321 
cytotoxicities with IC50 values of 2.60, 7.02, 1.47, 3.37, and 4.14 µM, respectively, better than 322 
that of the positive control doxorubicin (IC50 9.74 µM). Compound (−)-2 had weak cytotoxicity 323 
(IC50 > 50 µM) while all remaining resolved caged xanthones ((−)-1, (+)-1, (+)-2, (−)-3, (+)-3, 324 
and (+)-6) were found to be inactive. It is interesting to note that the levorotatory compounds 325 
showed cytotoxicity greater than their dextrorotatory counterparts. The structural difference 326 
between compounds 3 and 4 is only at C-3. Compound 3 contained a C-3 methoxy group 327 
whereas compound 4 had a C-3 hydroxy group which played an important role in the 328 
cytotoxicity. Also, the double bond at C-8/C-8a of compounds 5 and 6 might be a crucial 329 
structural element for cytotoxicity as indicated by the different potencies of the compounds 1 and 330 
2 [22].      331 
4. Conclusions  332 
Previous phytochemical studies of the stem bark [22], root [23] and twig [25] of G. 333 
propinqua, have resulted in the isolation of benzophenones, xanthones, and caged xanthones. In 334 
our studies, the latter two types of compounds were the major compounds of this plant. All caged 335 
xanthones previously isolated from this plant were scalemic mixtures. In the present study, we 336 
isolated an additional six scalemic caged xanthones (1-6) with enantiomeric ratios ranging from 337 
1:0.7 to 1:0.9. Interestingly, none of these compounds were isolated from the stem bark [22] and 338 
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twig [25] of this plant. These compounds were resolved by chiral HPLC and their absolute 339 
configurations were identified using X-ray crystallography and ECD spectroscopy. Five 340 
enantiomeric caged xanthones (‒)-4, (+)-4, (‒)-5, (+)-5, and (−)-6 showed potent cytotoxicities 341 
against a colon cancer cell line which may have potential for further development as anticancer 342 
lead compounds.  343 
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 449 
Fig. 1. Garcinia propinqua (These photos were taken by Surat Laphookhieo). 450 
451 
Fig. 2.  Compounds isolated from the leaves of G. propinqua. 452 
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Fig. 4. X-ray ORTEP diagrams of compounds (+)-2, (+)-3 and (±)-4. 459 
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   Fig. 5. ECD spectra of resolved compounds 1-6 in MeOH. 462 
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Table 1. 1H NMR spectroscopic data of compounds 1–5 (600 MHz in CDCl3). 479 
Position 1 2 3 4 5 
1 - - - - -  
2 6.08, s  6.02, s  6.08, s  6.02, s  6.12, s  
3 - - - - - 
4 - - - - - 
4a - - - - - 
5 - - - - - 
6 - - - - - 
7 2.88, dd (4.5, 5.9) 3.50, dd (4.9, 6.8) 3.73, m 3.76, dd (4.8, 6.7) 3.49, dd (5.1, 7.0) 
8 4.35, dd (4.4, 1,4) 7.47, d (6.8) 7.16, d (6.1) 7.19, d (6.7) 7.48, d (7.0) 
8a 3.30, d (1.4) - - - - 
9 - - - - - 
9a - - - - - 
10a - - - - - 
11 - - - - - 
12 6.24, dd (10.5,17.9) 4.54, q (6.7) 6.32, dd (11.1,17.1) 6.47, dd (10.4,17.8) 6.14, dd (10.6,17.3) 
13 5.35, d (17.9) 1.30, d (6.7) 4.86, d (17.1) 5.47, d (17.8) 4.76, d (17.3) 
 5.30, d (10.5)  4.75, d (11.1) 5.36, d (10.4) 4.69, d (10.6) 
14 1.62, s 1.42, s 1.60, s 1.72, s 1.66, s 
15 1.66, s 1.51, s 1.57, s 1.61, s 1.63, s 
16 2.86, dd (5.9, 14.6)  2.64, m 2.50, m 2.49, m 2.63, dd (7.7) 
 2.69, dd (9.1, 14.6)  2.07, dd (8.5, 14.4) 2.09, dd (8.1, 14.7)  
17 5.29, m 4.35, m 5.02, t (7.6) 5.02, t (7.6) 4.38, t (7.7) 
18 - - - - - 
19 1.62, s 1.38, s 1.72, s 1.73, s 1.40, s 
20 1.66, s 1.07, s 1.59, s 1.59, s 1.09, s 
21 1.97, dd (6.3, 14.7) 2.34, dd (4.9, 13.5) 2.50, m 2.49, m 2.33, dd (4.9, 13.4) 
 1.38, dd (8.7,14.7) 1.39, m 1.79, m 1.86, dd (9.9, 13.2) 1.31, dd (9.1, 13.4 
22 2.54, d (8.7) 2.55, dd (10.8, 14.3) 2.16, m 2.19, dd (4.8, 9.9) 2.49, d (9.1) 
23 - - - - - 
24 1.12, s 1.27, s 1.34, s 1.35, s 1.23, s 
25 1.39, s 1.74, s 1.35, s 1.36, s 1.69, s 
OH-1 12.09, s 13.15, s 12.77, s 12.54, s 13.27, s 
OH-3 6.96, s - - 7.52, s - 
OMe-3 - - 3.79, s - 3.77, s 
OMe-8 3.29, s - - - - 
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Table 2. 13C NMR spectroscopic data of compounds 1–5 (150 MHz in CDCl3).  
Position 1 2 3 4 5 
1 162.5 166.3 163.8 163.3 164.2 
2 99.5 92.6 94.1 99.2 94.0 
3 165.5 168.2 168.3 165.7 168.3 
4 111.4 112.4 114.4 111.5 113.6 
4a 158.0 156.5 158.3 159.8 159.3 
5 86.7 84.6 199.9 199.9 85.1 
6 209.1 203.9 79.4 79.2 204.3 
7 44.7 46.7 44.9 44.9 47.5 
8 74.6 134.4 134.2 134.2 134.2 
8a 47.2 135.0 135.0 134.3 133.5 
9 194.6 178.9 178.8 178.6 180.2 
9a 103.1 101.3 102.0 102.4 101.7 
10a 88.7 90.8 83.7 83.9 91.5 
11 41.4 43.7 40.9 41.4 41.6 
12 149.2 91.5 151.6 149.9 150.9 
13 113.4 15.9 106.1 113.3 106.7 
14 30.3 25.1 29.5 28.3 29.0 
15 27.3 19.6 29.0 27.6 28.0 
16 28.1 28.5 30.4 30.4 29.4 
17 117.8 117.5 117.6 117.4 118.2 
18 133.9 133.7 136.4 136.5 135.3 
19 18.0 25.5 18.3 18.3 25.7 
20 26.0 16.3 25.9 26.1 17.1 
21 20.2  27.8 32.8  32.9 26.6 
22 43.9  48.9 42.5  42.4 49.5 
23 81.1  83.0 83.6  83.9 83.3 
24 27.4  28.6 26.9  26.9 31.0 
25 30.5  30.5 29.7  29.7 31.4 
OMe-3 - - 55.6 - 55.5 
OMe-8 55.7 - - - - 
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Scheme 1. Plausible biosynthetic pathway of compounds 1–6. 492 
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